Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML

NCT01496547 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia

Interventions

DRUG: intensive chemo - RIC preparation

Sponsor

Shanghai Jiao Tong University School of Medicine